搜索
Search
img

R&D

研究开发

Product Pipeline

  • Categories:R&D
  • Time of issue:2020-03-12 00:00:00
  • Views:0
Description:
Description:
Information

After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on major cancers and other AR related diseases.

 

 

Note: 1.In addition, IND for basal-cell carcinoma indication has been cleared by FDA in the U.S.; 2. Will conduct phase II clinical trial directly due to good safety, and the protocol is under preparation

      mCRPC = metastatic castration-resistant prostate cancer

      HCC =hepatocellular carcinoma

      GC = gastric carcinoma

      GEJ = gastroesophageal junction

      UC = urothelial carcinoma

      ESCC = esophageal squamous cell carcinoma

      PROTAC = proteolysis targeting chimera

Scan the QR code to read on your phone